Amanote Research
Register
Sign In
Phase II Trial of Karenitecin in Patients With Malignant Melanoma: Clinical and Translational Study
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-04-1722
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
April 15, 2005
Authors
A. Daud
Publisher
American Association for Cancer Research (AACR)
Related search
Gene Regulatory and Clinical Effects of Interferon Β in Patients With Metastatic Melanoma: A Phase II Trial
Journal of Interferon and Cytokine Research
Medicine
Virology
Immunology
Cell Biology
A Phase I/Ii Study of Lomustine and Temozolomide in Patients With Cerebral Metastases From Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients With Stage IV Malignant Melanoma Without Prior Treatment: A Phase IIa Trial
Clinical Cancer Research
Cancer Research
Oncology
Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers
Oncologist
Cancer Research
Medicine
Oncology
A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Oncologist
Cancer Research
Medicine
Oncology
Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase II Trial of Tremelimumab (CP-675,206) in Patients With Advanced Refractory or Relapsed Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
